Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Dilon Technologies Inc. logo — Dilon Technologies is a medical device company that focuses...

Dilon Technologies Inc.

Dilon Technologies is a medical device company that focuses on products that assist in the fight against breast cancer.

Founded 1999 United States Newport News, United States 74 employees Debt Financing Total: $9.49M Biotechnology, Health Care

General Information

Company Name Dilon Technologies Inc.
Founded Year 1999
Location United States Newport News, United States
Employees 74
Industries Biotechnology, Health Care
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with Dilon Technologies Inc.. To contact Dilon Technologies Inc., visit dilon.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Dilon Technologies Inc. compare?

A PDF of Dilon Technologies Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Dilon Technologies Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Dilon Technologies Inc.

Dilon Technologies Inc. is a medical device company headquartered in the United States, specializing in products that aid in the battle against breast cancer. The company, established in 1999, boasts a robust medical device portfolio, which includes the Navigator System, a renowned surgical gamma probe for radio-guided lymphatic mapping and tumor localization, the MarginProbe, a pioneering technology for precise microscopic margin assessment in breast cancer surgery, and the TrueView 100 Pro, a Specimen Radiography System (SRS) utilizing advanced radiography and automated software to accurately identify tumor lesions in resected or biopsied breast tissue. In December 2013, the company secured a $3.95M investment through Debt Financing, signifying the confidence of investors in Dilon Technologies' vision and the potential for its innovations in the healthcare and biotechnology sectors. The absence of specific investment backers suggests that the company may have pursued this financing independently or through private channels, indicating a strategic and self-sufficient approach to funding its operations and advancements in the fight against breast cancer.

Business keywords: Breast Imaging, Molecular Breast Imaging, General Nuclear Medicine, Gamma Probes, Specimen Radiography System, Breast Cancer, Margin Assessment, Lymphatic Mapping, Breast Cancer Surgery, Tumor Localization, Microscopic Margin Assessment, Surgical Device, Cancer Surgery, Radiography

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $3.95M -
31 Dec 2013
Debt Financing $1.92M -
14 Nov 2011
Debt Financing $2.95M -
07 Sep 2010
Debt Financing $660.80K -
26 Feb 2009

Dilon Technologies Inc. Alternatives & Competitors

View All Alternatives
Dilon Technologies Inc. vs
Lumicell
Lumicell United States

Illuminate Cancer in Real Time

Venture round
63 employees
Biotechnology, Hardware
Compare Dilon Technologies Inc. vs Lumicell
Dilon Technologies Inc. vs
OncoRes Medical
OncoRes Medical Australia

Transforming the standard of care in breast cancer surgery.

42 employees
Biotechnology, Health Care
Dilon Technologies Inc. vs
IceCure Medical
IceCure Medical Israel

The Choice of Cryoablation

Post-IPO Equity
70 employees
Biotechnology, Health Care
View all alternatives

FAQ About Dilon Technologies Inc.

Dilon Technologies is a medical device company that focuses on products that assist in the fight against breast cancer.
Dilon Technologies Inc. was founded in 1999.
Dilon Technologies Inc. is headquartered in Newport News, United States.
Dilon Technologies Inc. operates in Biotechnology and Health Care. Its work centres on Breast Imaging, Molecular Breast Imaging, General Nuclear Medicine and Gamma Probes.
Dilon Technologies Inc. has approximately 74 employees.
Dilon Technologies Inc. has completed 4 funding rounds, raising a total of $9.49M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Dilon Technologies Inc. include Lumicell, OncoRes Medical, IceCure Medical, Vergent Bioscience, BoomRay Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Dilon Technologies Inc. and Lumicell are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Dilon Technologies Inc., https://bouncewatch.com/company/dilon-technologies-inc, updated 6 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout